Concepedia

Espen B. Ellingsen

EB

7

Publications

247

Citations

7

H-Index

2002

Active since

Affiliations

Oslo University Hospital(Current)

Ultimovacs (Norway)

University of Oslo

Science for Life Laboratory

Uppsala University

Espen B. Ellingsen is an author at Oslo University Hospital specializing in genetics, public health, and bioinformatics.

ORCID

Top concepts

Publications per year

2002–2023

7

Publications

7

Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14.

Espen B. Ellingsen, Siegfried Morath, Trude Helen Flo et al. · PubMed · 2002 · 89 citations

Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial

Elin Aamdal, Else Marit Inderberg, Espen B. Ellingsen et al. · Frontiers in Immunology · 2021 · 40 citations · Full text

Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials

Espen B. Ellingsen, Elin Aamdal, Tormod Kyrre Guren et al. · Journal for ImmunoTherapy of Cancer · 2022 · 36 citations · Full text

Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial

Espen B. Ellingsen, Steven O’Day, Artur Mezheyeuski et al. · Clinical Cancer Research · 2023 · 25 citations · Full text

NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma

Vilde Drageset Haakensen, Anna K. Nowak, Espen B. Ellingsen et al. · Journal of Translational Medicine · 2021 · 23 citations · Full text

Rows per page

1–5 of 7